Promising new Alzheimer’s drug candidate developed by international research team
A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of Alzheimer’s disease.
Promising 'first' in Alzheimer's drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on both major aggregation-promoting 'hotspots' of the Tau protein in the brain -- a key driver of neurodegeneration.
Alzheimer's 'First' Achieved With Drug That Hits Hotspots
The compound, called RI-AG03, is a novel peptide inhibitor—a short chain of amino acids designed to block the activity of specific proteins. In fruit fly models and lab experiments on human ...
New Alzheimer’s Drug, RI-AG03, Shows Promise in Preliminary Trials
A team of researchers has reported a significant advance in Alzheimer’s treatment. Their candidate drug, RI-AG03, attacks the accumulation of tau proteins—crucial to the disease’s progression—in lab and animal tests.
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
Researchers say they have sparked an “exciting” breakthrough in treating Alzheimer’s disease by developing a drug to prevent the build-up of toxic proteins in the brain. “This research is taking promising steps toward a new one-of-a-kind therapy which targets tau,
BioWorld4d
RI-AG03 targets main promoters of tau protein aggregation at once
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
Hosted on MSN1d
Alzheimer's disease could be stopped in its tracks by new drug with potential to 'prevent progression'
This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...
ScienceAlert on MSN1d
Breakthrough Alzheimer's Drug Targets Key 'Hotspots' to Suppress Toxic Tangles
The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...
Neuroscience News5d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
protothema.gr1d
Innovative Drug for Alzheimer’s Disease Brings New Hope for Treatment
A new drug targeting Tau protein shows promise in preventing its accumulation, potentially leading to more effective ...
Breakthrough Alzheimer’s drug successfully blocks both major disease ‘hotspots’ at once for the first time
RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...